Auswahl der wissenschaftlichen Literatur zum Thema „Antimicrobial resitance“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Antimicrobial resitance" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Antimicrobial resitance"
Djuikoue, Cecile Ingrid, Willy Yamdeu Djonkouh, Cavin Epie Bekolo, Rodrigue Kamga Wouambo, Raspail Carrel Founou, Paule Dana Djouela Djoulako, Gilder Tonfak Temgoua, Benjamin D. Thumamo Pokam, Nicolas Antoine-Moussiaux und Teke R. Apalata. „Prevalence and Antibiotic Resistance Pattern of Streptococcus, Staphylococcus, Neisseria meningitidis and Enterobacteriaceae in Two Reference Hospitals of Yaoundé: An Overview before and during COVID-19 Pandemic Era“. Antibiotics 12, Nr. 5 (18.05.2023): 929. http://dx.doi.org/10.3390/antibiotics12050929.
Der volle Inhalt der QuelleOlukemi, Alade Tolulope, Oladapo Olutoyosi, Nanighe Stephen, Okonte-Jonah Joshua und Mbam Raphael Emmanuel. „Assessment of OqxA and OqxB Resistance Genes in Escherichia coli and Klebsiella pnuemoniae Clinical Isolates Based on Polymerase Chain Reaction from Niger Delta University Teaching Hospital, Yenagoa, Bayelsa State“. East African Scholars Journal of Medical Sciences 6, Nr. 04 (29.04.2023): 141–46. http://dx.doi.org/10.36349/easms.2023.v06i04.005.
Der volle Inhalt der QuelleAnaya-Baz, Blanca, Natalia Maldonado, Zaira R. Palacios-Baena, Virginia Palomo, Maria Diletta Pezzani, Sheila Chiesi, Elisa Razzaboni, Monica Compri, Evelina Tacconelli und Jesús Rodriguez-Baño. „Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol“. BMJ Open 10, Nr. 5 (Mai 2020): e030608. http://dx.doi.org/10.1136/bmjopen-2019-030608.
Der volle Inhalt der QuelleChowdhury, Souradeep, Nisha Rathor und Rama Chaudhry. „1682. An Exciting New Approach: Isolation and characterisation of bacteriophages against MDR Acinetobacter baumannii“. Open Forum Infectious Diseases 9, Supplement_2 (01.12.2022). http://dx.doi.org/10.1093/ofid/ofac492.1312.
Der volle Inhalt der QuelleYergaliyeva, Ademi, Saya Gazezova, Gulzhan Ayapova, Elvira Ibragimova, Dilyara Nabirova und Roberta Horth. „2463. Bacterial Infections in Intensive Care Unit patients in a large general hospital, Kazakhstan, 2022“. Open Forum Infectious Diseases 10, Supplement_2 (27.11.2023). http://dx.doi.org/10.1093/ofid/ofad500.2081.
Der volle Inhalt der QuellePeterson, Lance R., Noelle I. Samia, Andrew M. Skinner, Amit Chopra und Becky Smith. „Antimicrobial Stewardship Lessons From Mupirocin Use and Resistance in Methicillin-Resitant Staphylococcus Aureus“. Open Forum Infectious Diseases 4, Nr. 2 (2017). http://dx.doi.org/10.1093/ofid/ofx093.
Der volle Inhalt der QuelleTalat, Absar, Fatima Khan und Asad U. Khan. „Genome analyses of colistin-resistant high-risk blaNDM-5 producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings“. BMC Microbiology 24, Nr. 1 (20.05.2024). http://dx.doi.org/10.1186/s12866-024-03306-4.
Der volle Inhalt der QuelleDissertationen zum Thema "Antimicrobial resitance"
Amarsy-Guerle, Rishma. „Analyse de la résistance aux antibiotiques et des infections nosocomiales à l'échelle d'une grande institution à travers les bases de données des laboratoires“. Electronic Thesis or Diss., Sorbonne université, 2024. http://www.theses.fr/2024SORUS018.
Der volle Inhalt der QuelleConsidered as a silent pandemic, antimicrobial resistance (AMR) is a major public health issue, that, combined with hospital-acquired infections (HAIs) threaten the quality and safety of hospital care. Monitoring antibiotic resistance and nosocomial infections is one of the cornerstones of preventing these phenomena. Surveillance programs are key in bringing a comprehensive knowledge of the current situation, essential for an effective implementation of prevention strategies. Surveillance of these phenomena can also be used for comparisons between facilities if we take care to take into account other factors of importance such as antibiotic and alcohol-based hand rub consumptions, and individual patient data.This thesis was conducted at the Assistance Publique - Hôpitaux de Paris (AP-HP), Europe's largest university hospital centre, during the COVID-19 pandemic. The significant rise in intensive care activities and antibiotic consumption has prompted us to redirect our objectives to assess the COVID-19 impacts on HAIs and AMR in our hospitals. Our study focused on bloodstream infections, by using data on blood cultures, collected from AP-HP bacteriology laboratories.We have demonstrated that this period was accompanied not only by an increase in the incidence of bacteraemia, but also in AMR among Enterobacteriales.Of interest, we have observed a decrease in invasive infections induced by Streptococcus pneumoniae and Streptococcus pyogenes, bacterial types which transmission can be controlled by wearing a mask.A review of a carbapenemase-producing Enterobacteriaceae (CPE) outbreak in an intensive care unit heavily impacted by the pandemic completes these studies.Additionally, we explore the irregularity of HAI and AMR rates within the AP-HP. This inconsistency cannot solely be attributed to variations in antibiotic consumption. Through the development of new indicators for resistance and infections, we have identified structural and organisational factors that are linked to a higher frequency of these phenomena.Individual patient factors, such as the severity of illness (case-mix), are likely to be associated with an increased risk of resistance. We will investigate this further in our future research using the AP-HP Clinical Data Warehouse.The systematisation of this surveillance over time will make it possible to identify priority areas and steer prevention policies and targeted actions